ROBERT L RECKER, M.D.
Osteopathic Medicine at Center Rd, Omaha, NE
License number
Nebraska 19686
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
7100 W Center Rd, Omaha, NE 68106
Phone
(402) 506-9112
(402) 261-0239 (Fax)
(402) 261-0239 (Fax)
Personal information
See more information about ROBERT L RECKER at radaris.comName
Address
Phone
5224 Jones St, Omaha, NE 68106
641 S Monitor St, West Point, NE 68788
3309 S 116Th St, Omaha, NE 68144
5711 45Th St, Lincoln, NE 68516
125 Lincoln St, West Point, NE 68788
Organization information
See more information about ROBERT L RECKER at bizstanding.comPhysicians-Internal Medicine - Robert L Recker MD
7710 Mercy Rd STE 601, Omaha, NE 68124
Categories:
Internal Medicine Physicians & Surgeons, Physicians & Surgeons
Phone:
(402) 397-5236 (Phone)
Robert L Recker MD
7710 Mercy Rd, Omaha, NE 68124
Industry:
Medical Doctor's Office
Medical Doctor, Principal:
Robert R. Recker Medical Doctor, Principal, inactive
Professional information
Robert Roy Recker, Omaha NE
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism
Work:
Creighton University
601 N 30Th St, Omaha, NE 68131 Alegent Health Central Billing Office
7500 Mercy Rd, Omaha, NE 68124 Physicians Of Internal Med
7710 Mercy Rd, Omaha, NE 68124
601 N 30Th St, Omaha, NE 68131 Alegent Health Central Billing Office
7500 Mercy Rd, Omaha, NE 68124 Physicians Of Internal Med
7710 Mercy Rd, Omaha, NE 68124
Education:
Creighton University (1963)
Robert L Recker, Omaha NE
Specialties:
Internist
Address:
7710 Mercy Rd, Omaha, NE 68124
2500 California Plz, Omaha, NE 68178
601 N 30Th St, Omaha, NE 68131
2500 California Plz, Omaha, NE 68178
601 N 30Th St, Omaha, NE 68131
Education:
Creighton University, School of Medicine - Doctor of Medicine
Creighton University Medical Center - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Creighton University Medical Center - Residency - Family Medicine
Creighton University Medical Center - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Creighton University Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Robert Libory Recker, Omaha NE
Specialties:
Internal Medicine, Endocrinology and Metabolism
Work:
Physicians of Internal Medicine
7710 Mercy Rd, Omaha, NE 68124
7710 Mercy Rd, Omaha, NE 68124
Education:
Creighton University (1993), Creighton University Medical Center - Sa *
Robert L Recker, Omaha NE
Specialties:
Internist
Address:
601 N 30Th St, Omaha, NE 68131
7710 Mercy Rd, Omaha, NE 68124
7710 Mercy Rd, Omaha, NE 68124
Education:
University of Nebraska, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
High Bone Mass Gene Of 11Q13.3
US Patent:
6770461, Aug 3, 2004
Filed:
Apr 5, 2000
Appl. No.:
09/544398
Inventors:
John P. Carulli - Southboro MA
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University School of Medicine - Omaha NE
Creighton University School of Medicine - Omaha NE
International Classification:
C12P 2100
US Classification:
435 701, 435325, 4352523, 4353201, 435 711, 435 712
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
High Bone Mass Gene Of 1.1Q13.3
US Patent:
6780609, Aug 24, 2004
Filed:
Apr 5, 2000
Appl. No.:
09/543771
Inventors:
John P. Carulli - Southboro MA
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Assignee:
Genome Therapeutics Corporation - Waltham MA
International Classification:
C12P 2106
US Classification:
435 691, 4353201, 435325, 435455, 4352521, 435471, 536 231, 536 235, 530350, 530380
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
High Bone Mass Gene Of 11Q13.3
US Patent:
2005014, Jun 30, 2005
Filed:
Apr 29, 2004
Appl. No.:
10/834377
Inventors:
John Carulli - Southboro MA, US
Randall Little - Newtonville MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Randall Little - Newtonville MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University School of Medicine - Omaha NE
Creighton University School of Medicine - Omaha NE
International Classification:
G01N033/53, G01N033/567, G01N033/569
US Classification:
435007200, 435007310
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
Treatment For Osteoporosis Using Grf Or A Biologically Active Analog Thereof
US Patent:
4870054, Sep 26, 1989
Filed:
Jul 31, 1987
Appl. No.:
7/080110
Inventors:
Robert R. Recker - Omaha NE
International Classification:
A61K 3736
US Classification:
514 12
Abstract:
A method of treating osteoporosis, especially post-menopausal osteoporosis, by administering on a periodic but regular basis to a patient growth hormone releasing factor, GRF(1-44)-NH. sub. 2, or a biologically active analog thereof, and continuing the administration until bone mass increases and the patient's calcium balance becomes positive and indicates a mineral accumulation in the skeleton.
Treatment For Osteoporosis Using Growth Hormone Releasing Factor (Grf) In Combination With Parathyroid Hormone (Pth)
US Patent:
5164368, Nov 17, 1992
Filed:
Nov 4, 1991
Appl. No.:
7/787051
Inventors:
Robert R. Recker - Omaha NE
International Classification:
A61K 3736
US Classification:
514 12
Abstract:
A method of treating osteoporosis, especially postmenopausal osteoporosis, by administering on a periodic but regular basis to a patient growth hormone releasing factor, GRF(1-44)-NH. sub. 2, or a biologically active analog thereof, and concurrently administering parathyroid hormone, PTH(1-34)-NH. sub. 2 and continuing the administration until bone mass increases and the patient's calcium balance becomes positive and indicates a mineral accumulation in the skeleton.
Genetic Markers To Detect High Bone Mass
US Patent:
5691153, Nov 25, 1997
Filed:
Sep 6, 1996
Appl. No.:
8/708175
Inventors:
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Donald B. Kimmel - Omaha NE
Guodong Gong - Omaha NE
Susan M. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Donald B. Kimmel - Omaha NE
Guodong Gong - Omaha NE
Susan M. Recker - Omaha NE
Assignee:
Creighton University - Omaha NE
International Classification:
C12Q 168
US Classification:
435 6
Abstract:
The invention provides the chromosome location of an autosomal dominant gene associated with high bone mass. As a result of this localization, the presence of a polymorphism linked to the autosomal dominant gene in a subject can be detected by analyzing human chromosome 11 of the subject for the presence of the polymorphism located about 30 cM around D11S987 and linked to the autosomal dominant gene. The analysis of chromosome 11 can be accomplished by amplifying the polymorphism, separating the amplified polymorphism to generate a polymorphism pattern, and correlating the presence or absence of the polymorphism with the respective presence or absence of the autosomal dominant gene associated with high bone mass.